Hypersensitivity reactions
This anti-IL-1 agent is normally well tolerated and indicated as an alternative in cases with an anaphylactic reaction to anakinra (135). However, there is a recently reported case who developed immediate diffuse urticaria after the tenth canakinumab administration and was prevented from further reactions with cetirizine premedication (134).